Literature DB >> 1460540

Isologous monoclonal antibodies can induce anti-GBM glomerulonephritis in rats.

Y Sado1, M Kagawa, S Rauf, I Naito, C Moritoh, T Okigaki.   

Abstract

Injection of isologous monoclonal antibodies (SR2, SR3) caused anti-glomerular basement membrane antibody-induced glomerulonephritis (anti-GBM nephritis) in WKY/NCrj rats. The antibodies were obtained from hybridoma cells derived from fusion of the spleen of a nephritic WKY/NCrj rat injected with rat solubilized renal basement membranes with adjuvant, and mouse SP2-myeloma cells. They belonged to the rat IgG2a subclass and bound to rat kidney in a linear pattern along the glomerular and tubular basement membranes. Histological changes in glomeruli were detected at day 1 after the injection; proteinuria with haematuria appeared on day 2; and proteinuria became severe and reached a plateau by day 5. These results demonstrate that anti-GBM nephritis can even be induced by an isologous monoclonal antibody and that the rat IgG2a subclass is at least nephritogenic. The experimental model of anti-GBM nephritis with isologous monoclonal antibodies makes it possible and easier to analyse further the mechanism of anti-GBM nephritis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1460540     DOI: 10.1002/path.1711680211

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  7 in total

1.  What sensitized cells just might be doing in glomerulonephritis.

Authors:  W Kline Bolton
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

2.  Nephritogenicity and alpha-chain composition of NC1 fractions of type IV collagen from bovine renal basement membrane.

Authors:  S Rauf; M Kagawa; Y Kishiro; S Inoue; I Naito; T Oohashi; M Sugimoto; Y Ninomiya; Y Sado
Journal:  Virchows Arch       Date:  1996-07       Impact factor: 4.064

3.  Establishment by the rat lymph node method of epitope-defined monoclonal antibodies recognizing the six different alpha chains of human type IV collagen.

Authors:  Y Sado; M Kagawa; Y Kishiro; K Sugihara; I Naito; J M Seyer; M Sugimoto; T Oohashi; Y Ninomiya
Journal:  Histochem Cell Biol       Date:  1995-10       Impact factor: 4.304

4.  Type IV collagen alpha 5 chain. Normal distribution and abnormalities in X-linked Alport syndrome revealed by monoclonal antibody.

Authors:  K Yoshioka; S Hino; T Takemura; S Maki; J Wieslander; Y Takekoshi; H Makino; M Kagawa; Y Sado; C E Kashtan
Journal:  Am J Pathol       Date:  1994-05       Impact factor: 4.307

5.  Monoclonal Suncus Antibodies: Generation of Fusion Partners to Produce Suncus-Suncus Hybridomas.

Authors:  Yoshikazu Sado; Satoko Inoue; Yasuko Tomono; Makoto Matsuyama; Masaki Fukushima; Toshitaka Oohashi; Takamichi Jogahara; Sen-Ichi Oda
Journal:  Acta Histochem Cytochem       Date:  2017-04-15       Impact factor: 1.938

6.  Creation of X-linked Alport syndrome rat model with Col4a5 deficiency.

Authors:  Tomoe Kobayashi; Mayumi Kohno; Masumi Namba; Takayuki Koyano; Takuo Hirose; Masaki Fukushima; Makoto Matsuyama
Journal:  Sci Rep       Date:  2021-10-21       Impact factor: 4.996

7.  Successful production of genome-edited rats by the rGONAD method.

Authors:  Tomoe Kobayashi; Masumi Namba; Takayuki Koyano; Masaki Fukushima; Masahiro Sato; Masato Ohtsuka; Makoto Matsuyama
Journal:  BMC Biotechnol       Date:  2018-04-02       Impact factor: 2.563

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.